Metropolitan Life Insurance Company (MetLife)’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,497
| Closed | -$23.6K | – | 2366 |
|
|
2023
Q4 | $23.6K | Hold |
1,497
| – | – | ﹤0.01% | 1843 |
|
|
2023
Q3 | $11.6K | Hold |
1,497
| – | – | ﹤0.01% | 2150 |
|
|
2023
Q2 | $14.9K | Hold |
1,497
| – | – | ﹤0.01% | 2088 |
|
|
2023
Q1 | $8.68K | Hold |
1,497
| – | – | ﹤0.01% | 2206 |
|
|
2022
Q4 | $11.9K | Buy |
+1,497
| New | +$11.9K | ﹤0.01% | 2229 |
|
|
2022
Q2 | – | Sell |
-1,796
| Closed | -$12.6K | – | 2455 |
|
|
2022
Q1 | $12.6K | Sell |
1,796
-2,181
| -55% | -$15.4K | ﹤0.01% | 2227 |
|
|
2021
Q4 | $91K | Hold |
3,977
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q3 | $118K | Buy |
+3,977
| New | +$118K | ﹤0.01% | 2433 |
|